Cited by 181Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration MechanismsNeurological diseases and metabolism

Neuropathology of multiple system atrophy: New thoughts about pathogenesis

Jellinger, Kurt A.·2014·Movement Disorders

Abstract

Multiple system atrophy (MSA) is a fatal adult‐onset neurodegenerative disorder of uncertain etiology, clinically manifesting with autonomic failure associated with parkinsonism, cerebellar dysfunction, and pyramidal signs in variable combination. The pathological process affects central autonomic, striatonigral, and olivopontocerebellar systems. These show varying degrees of neurodegeneration and underlie the stratification of the heterogenous disorder into MSA‐P and MSA‐C clinical variants, which correlate to the morphologic phenotypes of striatonigral degeneration and olivopontocerebellar atrophy (MSA‐C). The lesions are not limited to these most consistently and severely affected systems but may involve many other parts of the central, peripheral, and autonomic nervous systems, underpinning the multisystem character of MSA. The histological core feature are glial cytoplasmic inclusions (GCIs, Papp‐Lantos bodies) in all types of oligodendroglia that contain aggregates of misfolded α‐Synuclein (α‐Syn). In addition to the ectopic appearance of α‐Syn in oligodendrocytes and other cells, oxidative stress, proteasomal and mitochondrial dysfunction, excitotoxiciy, neuroinflammation, metabolic changes, and energy failure are important contributors to the pathogenesis of MSA, as shown by various neurotoxic and transgenic animal models. Although the basic mechanisms of α‐Syn–triggered neurodegeneration are not completely understood, neuron‐to‐oligodendrocyte transfer of α‐Syn by prion‐like spreading, inducing oligodendroglial and myelin dysfunction associated with chronic neuroinflammation, are suggested finally to lead to a system‐specific pattern of neurodegeneration. © 2014 International Parkinson and Movement Disorder Society

Integrity signals

Registry

Crossref · 10.1002/mds.26052

Cites

288 of 288 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In MSA, in addition to GCIs, myelin degeneration, axonal damage, loss of neurotrophic support, neuronal loss, astrogliosis and microglial activation are pathological events seen in multiple regions of the central nervous system.

    “The precise pathogenesis of MSA remains largely unknown, however, evidence from human postmortem cases and experimental models suggest that, in addition to GCIs, myelin degeneration, axonal damage, loss of neurotrophic support, neuronal loss, astrogliosis and microglial activation are pathological events seen in multiple regions of the central nervous system (CNS) [28, 56].”
  • The model recapitulates early pathogenesis seen in MSA, as many of the pathological features induce dysfunction of the oligodendroglia-myelin-axon-neuron complex.

    “Our model recapitulates early pathogenesis seen in MSA, as many of the pathological features induce dysfunction of the oligodendroglia-myelin-axon-neuron complex [28].”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jellinger, K. A.
Affiliations
Institute of Clinical Neurobiology Vienna Austria
Corresponding author
Jellinger, Kurt A.
Venue
Movement Disorders
Publisher
Wiley
Published
2014-10-09
Volume
29
Issue
14
Pages
1720-1741
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W1902295431
Cited by
181
References
288
Citations by year
2026: 8 · 2025: 11 · 2024: 22 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 15 · 2019: 20 · 2018: 16 · 2017: 18 · 2016: 15 · 2015: 13
FWCI
2.11
Type
journal article
Language
en
Open access
closed
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
multiple system atrophy, neuropathology, pathogenesis, glial cytoplasmic inclusions, alpha-synuclein, oligodendrocytes, autonomic failure, parkinsonism, cerebellar dysfunction, striatonigral degeneration, olivopontocerebellar atrophy, neuroinflammation, oxidative stress, mitochondrial dysfunction, prion-like spreading, neurodegeneration
MeSH terms
Animals, Humans, Nervous System Diseases, Neurons, Oligodendroglia, Shy-Drager Syndrome, Multiple System Atrophy, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review